Pitt Shield

Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier.

Authors: Burgess A, Ayala-Grosso CA, Ganguly M, Jordão JF, Aubert I, Hynynen K

Stem cell therapy is a promising strategy to treat neurodegenerative diseases, traumatic brain injury, and stroke. For stem cells to progress towards clinical use, the risks associated with invasive intracranial surgery used to deliver the cells to the brain, needs to be reduced. Here, we show that MRI-guided focused ultrasound (MRIgFUS) is a novel method for non-invasive delivery of stem cells from the blood to the brain by opening the blood brain barrier (BBB) in specific brain regions. We used MRI guidance to target the ultrasound beam thereby delivering the iron-labeled, green fluorescent protein (GFP)-expressing neural stem cells specifically to the striatum and the hippocampus of the rat brain. Detection of cellular iron using MRI established that the cells crossed the BBB to enter the brain. After sacrifice, 24 hours later, immunohistochemical analysis confirmed the presence of GFP-positive cells in the targeted brain regions. We determined that the neural stem cells expressed common stem cell markers (nestin and polysialic acid) suggesting they survived after transplantation with MRIgFUS. Furthermore, delivered stem cells expressed doublecortin in vivo indicating the stem cells were capable of differentiating into neurons. Together, we demonstrate that transient opening of the BBB with MRIgFUS is sufficient for transplantation of stem cells from the blood to targeted brain structures. These results suggest that MRIgFUS may be an effective alternative to invasive intracranial surgery for stem cell transplantation.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To determine whether MRI-guided focused ultrasound can noninvasively deliver neural stem cells from the bloodstream into targeted brain regions by transiently opening the blood–brain barrier.
Animal model / Human subject Rat; strain None; age None; sex None
Disease model healthy
MRI or image guidance method MRI-guided focused ultrasound (MRIgFUS); MRI guidance was used to target the ultrasound beam to the striatum and hippocampus.
Targeted brain region(s) Striatum
Cargo name and characteristics Neural stem cells (NSCs) — iron-labeled for MRI detection and genetically modified to express green fluorescent protein (GFP); express stem cell markers (nestin, polysialic acid) and show neuronal differentiation marker (doublecortin) after delivery to targeted brain regions.
Route of administration intravenous

Outcomes and Safety

Summary of Outcomes MRI-guided focused ultrasound transiently opens the blood–brain barrier to enable targeted delivery of neural stem cells into the striatum and hippocampus, where they survive at least 24 hours and express stem cell and immature neuronal markers with minimal tissue damage.
Duration of biological effect 24 hours
Safety-related matter MRIgFUS resulted in minimal tissue damage but caused red blood cell extravasation and can produce edema at high BBB enhancement (>30%); immunological/inflammatory reactions remain uncharacterized, though the method may reduce surgical risks such as infection and hemorrhage.

Brain Region

Ultrasound Parameters

Ultrasound instrument None.
Treatment frequency single session

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search